Business Insights and Analytics

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Read more

Strategic and Scientific Consulting

Our Consulting team help solve complex scientific and commercial challenges and drive strategy throughout the product lifecycle

Read more

Scientific and Creative Communications

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Read more

Business Insights and Analytics

Plus icon

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Read more

Strategic and Scientific Consulting

Plus icon

Our Consulting team help solve complex scientific and commercial challenges and drive strategy throughout the product lifecycle

Read more

Scientific and Creative Communications

Plus icon

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Read more

Why we do what we do

The healthcare industry is going through fundamental change and in this uncertainty our clients need to convert great science into winning strategy

Our clients tell us they need our support in making the right strategic decisions that ensure their products fulfill their potential and ultimately improve people’s lives

We love working at the cutting edge, helping to tackle our clients’ newest and most complex problems

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of biotechs globally from our offices in the US and Europe

Solving unique problems

Whether we are supporting you on your journey, or delivering specialist expertise, we are helping you make important choices

Share our fresh thinking >

Are We Nearing the Plateau of Productivity for in-vivo Therapeutic Gene Editing?
Are We Nearing the Plateau of Productivity for in-vivo Therapeutic Gene Editing?
Amidst success of in vivo adeno-associated virus (AAV) based gene therapies, the gene therapy community awaits key outcomes from next month’s Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) meeting discussing toxicities and deaths associated with high titer AAV dosing and potential long-term adverse events.
Evolution of the New Decade of China Biopharma: Investing in the Future and Thinking Globally
Evolution of the New Decade of China Biopharma: Investing in the Future and Thinking Globally
The recent Chinese biopharma boom has been driven by six main factors: 1) Abundance of capital (government subsidies/funding, private funding, public markets); 2) Traditional generics industry being de-emphasized (4+7 scheme to centralize generic drug procurement and pricing); 3) High unmet need in key therapeutic areas (oncology/infectious diseases/inflammatory diseases); 4) Western-trained returnees (so-called “sea turtles”); 5) Significant investment in R&D moving away from licensing life.
Precision vs Imprecision Oncology
Precision vs Imprecision Oncology
I got to thinking recently about the push towards developing drugs for molecularly stratified patient populations, including a spate of approvals over the past few years for agents targeting aberrantly expressed (mutated, translocated, amplified, etc.
Silver Lining to Approval of Aducanumab?
Silver Lining to Approval of Aducanumab?
The accelerated and broad label approval of Biogen’s Alzheimer's Disease (AD) drug aducanumab (Aduhelm) is controversial (to say the least) on many fronts, ranging from:(1) validity of the amyloid biomarker data that formed the basis of approval(2) expansive label indicating all AD patients despite an extremely heterogenous population with differing levels of disease severity, disease progression and comorbidities(3) uncertainty amongst prescribers and patients and caregivers about which.

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today.